Cannabis Stocks Are "No Place to Put Your Money" Reviewers Warn
FN Media Group Presents USA News Group News Commentary
LOS ANGELES, Oct. 23, 2019 /PRNewswire/ -- USA News Group – While it may appear very enticing to jump in on the legalization of cannabis by investing in the sector, leading reviewers are coming out strong against putting your money in pot stocks. They say it's no place for your money.
In just the past several months, cannabis stocks have been taking a beating and that fact should serve as a warning to investors as to what's really taking place in many of the companies that have flooded the small cap markets. Companies including C21 Investment Inc. (CSE: CXXI) (OTCQB: CXXIF), Beleave Inc. (CSE: BE) (OTCMKTS: BLEVF) and Iconic Brands Inc. (OTCQB: ICNB) have made a good show of entering the legal marijuana market, but the numbers don't seem to indicate they are profitable.
It's obvious the cannabis industry is experiencing a bubble and as such, you would expect companies to pop up and promise goodies, which will in turn elevate their value. An especially damaging statistic about emerging cannabis companies is that most are not profitable, even after several years of development. Invictus MD Strategies Corp (OTCQX: IVITF) (TSX-V: GENE), for example, has been in the business since 2014 but has yet to turn a profit. In the last twelve months, the company has seen its stock decline by 90% with a continuous stream of negative news. Investors, and certainly institutions, will likely steer clear until something is done to turn the company around. Invictus appears to have run out of money and looks as though they are doing their best to band-aid their payroll, it's probably just a short matter of time until we see this company filing for Bankruptcy.
Invictus losses have been mounting for years at an astonishing rate:
2017: EBITA was -6,054,000
2018: EBITA was -15,100,000
2019: EBITA was -33,410,000
Source: https://ca.finance.yahoo.com/quote/GENE.V/financials?p=GENE.V
The recent implosion of marijuana stocks has put Invictus as well as many other Marijuana companies into red alert situations. Most are having extreme difficulty to raise any capital to keep the lights on. Invictus has had to make major management changes, including Trevor Dixon the CEO and director of the company. The stress to keep the company alive seems to be talking its toll on management and the company's share price. Invictus share price started the year at $1.69 and has continuously fallen to the current price of 0.16.
An Industry Built on Hope and Hype
The marijuana industry is currently growing at a phenomenal rate thanks to its decriminalization in various jurisdictions. For years, it has been illegal to grow sell and process pot since it was a "Schedule 1 drug" on the same prohibitive list as heroin. But the laws have changed and in Canada, for instance, they have legalized recreational cannabis use. A number of states, including California, have followed suit. There is hope among its proponents that marijuana will be legal at the federal level as more legislators have been advocating for the substance in recent times.
Marketers have successfully promoted the cannabis sector and that has gotten many investors interested. Investors have been pumping millions of dollars into the cannabis industry with the promise of incredible returns, but this may all be a dangerous gamble, and not one the small guy should be taking.
Pressure to Perform
Pot is a commodity regardless of how or where it is grown. Proponents of marijuana will argue that different varieties give a different feeling when consumed. They will highlight the presence of THC and CBD and its medicinal significance, but all this hype is irrelevant to investors. Regardless of how many varieties of pot are there or how many uses it can be used in, it is still pot and nothing more. Versatility won't make it lucrative and just like all commodities; it has to deal with market dynamics.
The reality is that many of the companies are just not coming through with the goods. For example, Invictus MD Strategies has been in the business for over 4 years, but it is not making profits. That's common to small cap and growth cannabis stocks. In the case of Invictus, numerous acquisitions and news of major celebrity endorsements have enticed investors as they believe the company is creating a sustainable model. However, investors need to look closely at the recent events in the company.
Invictus has issued a raft of negative news releases about the company in 2019. These include major fundamental shifts in the company's business. It has been forced to sell off major assets such as Future Harvest Developments and Canandia Bioceuticals, which the company had originally held as value assets. Then in August, front man and rock legend Gene Simmons dropped the company from his endorsement role as Chief Evangelist. Those and other events have upended the company so much that it has been forced to reorganize its entire management. That's another serious red flag for a growth company.
Based on the flurry of constant setbacks, Invictus MD Strategies' shares have dropped 90% in the last year. It would be easy enough to attribute that to slumps and growing pains in a young company, but Invictus has been shedding its value for the last three years. Equally important, the company has not managed to convince investors that their struggles are over yet. That's going to make it incredibly hard to attract and keep investors.
Invictus is a clear example of where most of the emerging cannabis companies are headed. For reviewers, that's not a good sign. They are predicting things are going to get tougher and tougher as the market matures. So, buying into the hype of promising prospects could be an investor's worst mistake.
Enhanced competition
In the last three years, cannabis prices have been reduced by more than half as competition intensifies. Growing competition is what cannabis companies such as Invictus MD Strategies have to contend with. In Oregon, which was the first to legalize pot in 2015, there were handful growers then and they enjoyed high prices. But that's shifted to the point where they are making half of what they used to.
Competition in the cannabis industry is now intense and more companies are flooding the market. The industry is staring at major price compression, which could result in most cannabis stocks falling apart. Industry leaders such as Canopy Growth Corp. and Tilray almost doubled their revenue last year, but even their stock prices tanked.
After much hype, most investors are starting to fold out of cannabis stocks. Some industry segments might present opportunities going forward, but growing competition means that the margins will be diminished. Investing in this cannabis sector now poses a high risk and as pundits put it, "is no place to put your money."
High profile emerging companies that are participating in the small cap market for cannabis include:
C21 Investment Inc. (CSE: CXXI) (OTCQB: CXXIF) is a cannabis operator based in Canada. it focuses on cultivation, processing distributing and marketing of cannabis products. It owns the Phantom Farms, Silver State Relief, Swell companies, and Eco Firm Farms. The company has lost over 83% of its share value to date in 2019.
Beleave Inc. (CSE: BE) (OTCMKTS: BLEVF) is a Canadian medical cannabis operator that grows and sells recreational and medical marijuana products. The company has recently announced the pending sale of two of its main operations in Saskatchewan and Ontario, Canada. The company has never been profitable and its last reported a net-loss for the three-month period ending December 31, 2018 was $2,260,015 or $0.01 per share.
Iconic Brands Inc. (OTCQB: ICNB) is a company that specializes in the development of beverages for itself and other entities. The company focuses on capital raising and identification of investment opportunities in running enterprises. Iconic Brands has not been profitable to date and shows a net loss of $0.07 cents per share in its last quarterly report ending June 2019.
For a more information about developments in the marijuana space and potential pitfalls of current small cap marijuana stocks, see the article at USA News Group: https://usanewsgroup.com/2019/08/12/gene-simmons-leaves-role-as-chief-evangelist-for-invictus-md-strategies/
Article Source:
USA News Group
http://usanewsgroup.com
info@usanewsgroup.com
DISCLAIMER: USA News Group is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with USA News Group or any company mentioned herein. The commentary, views and opinions expressed in this release by USA News Group are solely those of USA News Group and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact Information:
FN Media Group, LLC
Media Contact e-mail:
editor@financialnewsmedia.com
U.S. Phone: +1(954)345-0611
Related Links
SOURCE USA News Group
Share this article